| [1] |
Sejvar JJ， Baughman AL， Wise M，et al.Population incidence of Guillain-Barré syndrome：a systematic review and meta-analysis[J]． Neuroepidemiology， 2011， 36(2)：123-133.DOI： 10.1159/000324710.
|
| [2] |
Asbury AK， Arnason BGW， Karp HR，et al.Criteria for diagnosis of Guillain-Barré syndrome[J]． Ann Neurol， 1978， 3(6)：565-566.DOI： 10.1002/ana.410030628.
|
| [3] |
Asbury AK， Cornblath DR.Assessment of current diagnostic criteria for Guillain-Barré syndrome[J]． Ann Neurol， 1990(27 Suppl)：S21-S24.DOI： 10.1002/ana.410270707.
|
| [4] |
Sejvar JJ， Kohl KS， Gidudu J，et al.Guillain-Barré syndrome and Fisher syndrome：case definitions and guidelines for collection，analysis，and presentation of immunization safety data[J]． Vaccine， 2011， 29(3)：599-612.DOI： 10.1016/j.vaccine.2010.06.003.
|
| [5] |
Hadden RD， Cornblath DR， Hughes RA，et al.Electrophysiological classification of Guillain-Barré syndrome：clinical associations and outcome.Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group[J]． Ann Neurol， 1998， 44(5)：780-788.DOI： 10.1002/ana.410440512.
|
| [6] |
|
| [7] |
van den Berg B， Bunschoten C， van Doorn PA，et al.Mortality in Guillain-Barre syndrome[J]． Neurology， 2013， 80(18)：1650-1654.DOI： 10.1212/WNL.0b013e3182904fcc.
|
| [8] |
Domínguez-Moreno R，Tolosa-Tort P，Patiño-Tamez A，et al.Mortality associated with a diagnosis of Guillain-Barré syndrome in adults of Mexican health institutions[J]．Rev Neurol，2014，58(1)：4-10.
|
| [9] |
Dourado ME， Félix RH， da Silva WK，et al.Clinical characteristics of Guillain-Barré syndrome in a tropical country：a Brazilian experience[J]． Acta Neurol Scand， 2012， 125(1)：47-53.DOI： 10.1111/j.1600-0404.2011.01503.x.
|
| [10] |
Fokke C， van den Berg B， Drenthen J，et al.Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria[J]． Brain， 2014， 137(Pt 1)：33-43.DOI： 10.1093/brain/awt285.
|
| [11] |
Doets AY， Verboon C， van den Berg B，et al.Regional variation of Guillain-Barré syndrome[J]． Brain， 2018， 141(10)：2866-2877.DOI： 10.1093/brain/awy232.
|
| [12] |
Ruts L， Drenthen J， Jacobs BC，et al.Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome：a prospective study[J]． Neurology， 2010， 74(21)：1680-1686.DOI： 10.1212/WNL.0b013e3181e07d14.
|
| [13] |
Kleyweg RP， van der Meché FG.Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange[J]． J Neurol Neurosurg Psychiatry， 1991， 54(11)：957-960.DOI： 10.1136/jnnp.54.11.957.
|
| [14] |
Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, et al.Recurrences，vaccinations and long-term symptoms in GBS and CIDP[J]． J Peripher Nerv Syst， 2009， 14(4)：310-315.DOI： 10.1111/j.1529-8027.2009.00243.x.
|
| [15] |
Principi N， Esposito S．Vaccine-preventable diseases，vaccines and Guillain-Barre' syndrome[J]． Vaccine， 2019， 37(37)：5544-5550.DOI： 10.1016/j.vaccine.2018.05.119.
|
| [16] |
Yuki N．Infectious origins of，and molecular mimicry in，Guillain-Barré and Fisher syndromes[J]． Lancet Infect Dis， 2001， 1(1)：29-37.DOI： 10.1016/S1473-3099(01)00019-6.
|
| [17] |
Yoshikawa K， Kuwahara M， Morikawa M，et al.Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases[J]． Neurol Neuroimmunol Neuroinflamm， 2018， 5(6)：e501.DOI： 10.1212/NXI.0000000000000501.
|
| [18] |
Jacobs BC， Rothbarth PH， van der Meché FG，et al.The spectrum of antecedent infections in Guillain-Barré syndrome：a case-control study[J]． Neurology， 1998， 51(4)：1110-1115.DOI： 10.1212/wnl.51.4.1110.
|
| [19] |
World Health Organization.Zika situation report [R/OL]．(2016-02-05)[2023-02-27]．2016)．
URL
|
| [20] |
Cao-Lormeau VM， Blake A， Mons S，et al.Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia：a case-control study[J]． Lancet， 2016， 387(10027)：1531-1539.DOI： 10.1016/S0140-6736(16)00562-6.
|
| [21] |
Parra B, Lizarazo J, Jiménez-Arango JA, et al. Guillain-Barré syndrome associated with zika virus infection in Colombia[J]． N Engl J Med， 2016， 375(16)：1513-1523.DOI： 10.1056/NEJMoa1605564.
|
| [22] |
Wilder-Smith A, Preet R, Renhorn KE, et al. ZikaPLAN：Zika preparedness latin American network[J]． Glob Health Action， 2017， 10(1)：1398485.DOI： 10.1080/16549716.2017.1398485.
|
| [23] |
Jacobs BC， van den Berg B， Verboon C，et al.International Guillain-Barré Syndrome Outcome Study：protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome[J]． J Peripher Nerv Syst， 2017， 22(2)：68-76.DOI： 10.1111/jns.12209.
|
| [24] |
Ropper AHW，Wijdicks EFM，Truax BT.Guillain-Barré Syndrome[M]．Philadelphia，Davis FA Company，1991：155-160.
|
| [25] |
van den Berg B, Walgaard C, Drenthen J, et al. Guillain-Barré syndrome：pathogenesis，diagnosis，treatment and prognosis[J]． Nat Rev Neurol， 2014， 10(8)：469-482.DOI： 10.1038/nrneurol.2014.121.
|
| [26] |
Ruts L, Drenthen J, Jongen JL, et al. Pain in Guillain-Barre syndrome：a long-term follow-up study[J]． Neurology， 2010， 75(16)：1439-1447.DOI： 10.1212/WNL.0b013e3181f88345.
|
| [27] |
Korinthenberg R， Schessl J， Kirschner J．Clinical presentation and course of childhood Guillain-Barré syndrome：a prospective multicentre study[J]． Neuropediatrics， 2007， 38(1)：10-17.DOI： 10.1055/s-2007-981686.
|
| [28] |
Roodbol J， de Wit MC， Walgaard C，et al.Recognizing Guillain-Barre syndrome in preschool children[J]． Neurology， 2011， 76(9)：807-810.DOI： 10.1212/WNL.0b013e31820e7b62.
|
| [29] |
Yuki N， Kokubun N， Kuwabara S，et al.Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes[J]． J Neurol， 2012， 259(6)：1181-1190.DOI： 10.1007/s00415-011-6330-4.
|
| [30] |
Ito M， Kuwabara S， Odaka M，et al.Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum：clinical analysis of 581 cases[J]． J Neurol， 2008， 255(5)：674-682.DOI： 10.1007/s00415-008-0775-0.
|
| [31] |
Wakerley BR， Uncini A， Yuki N，et al.Guillain-Barré and Miller Fisher syndromes-new diagnostic classification[J]． Nat Rev Neurol， 2014， 10(9)：537-544.DOI： 10.1038/nrneurol.2014.138.
|
| [32] |
Sekiguchi Y， Mori M， Misawa S，et al.How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis？[J]． Eur J Neurol， 2016， 23(6)：1058-1063.DOI： 10.1111/ene.12983.
|
| [33] |
Uncini A， Yuki N．Sensory Guillain-Barré syndrome and related disorders：an attempt at systematization[J]． Muscle Nerve， 2012， 45(4)：464-470.DOI： 10.1002/mus.22298.
|
| [34] |
Odaka M, Yuki N, Yamada M, et al. Bickerstaff's brainstem encephalitis：clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome[J]． Brain， 2003， 126(Pt 10)：2279-2290.DOI： 10.1093/brain/awg233.
|
| [35] |
Ito M, Matsuno K, Sakumoto Y, et al. Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum[J]． J Neurol Neurosurg Psychiatry， 2011， 82(3)：294-299.DOI： 10.1136/jnnp.2010.222836.
|
| [36] |
Graus F， Titulaer MJ， Balu R，et al.A clinical approach to diagnosis of autoimmune encephalitis[J]． Lancet Neurol， 2016， 15(4)：391-404.DOI： 10.1016/S1474-4422(15)00401-9.
|
| [37] |
van den Berg B, van der Eijk AA, Pas SD, et al. Guillain-Barré syndrome associated with preceding hepatitis E virus infection[J]． Neurology， 2014， 82(6)：491-497.DOI： 10.1212/WNL.0000000000000111.
|
| [38] |
Vellozzi C， Iqbal S， Broder K．Guillain-Barre syndrome，influenza，and influenza vaccination：the epidemiologic evidence[J]． Clin Infect Dis， 2014， 58(8)：1149-1155.DOI： 10.1093/cid/ciu005.
|
| [39] |
Thornton CA, Latif AS, Emmanuel JC. Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe[J]． Neurology， 1991， 41(6)：812-815.DOI： 10.1212/wnl.41.6.812.
|
| [40] |
Islam B, Islam Z, GeurtsvanKessel CH, et al. Guillain-Barré syndrome following varicella-zoster virus infection[J]． Eur J Clin Microbiol Infect Dis， 2018， 37(3)：511-518.DOI： 10.1007/s10096-018-3199-5.
|
| [41] |
Carod-Artal FJ， Wichmann O， Farrar J，et al.Neurological complications of dengue virus infection[J]． Lancet Neurol， 2013， 12(9)：906-919.DOI： 10.1016/S1474-4422(13)70150-9.
|
| [42] |
Wielanek AC, Monredon JD, Amrani ME, et al. Guillain-Barré syndrome complicating a Chikungunya virus infection[J]． Neurology， 2007， 69(22)：2105-2107.DOI： 10.1212/01.wnl.0000277267.07220.88.
|
| [43] |
Cornblath DR, McArthur JC, Kennedy PG, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection[J]． Ann Neurol， 1987， 21(1)：32-40.DOI： 10.1002/ana.410210107.
|
| [44] |
Schonberger LB， Bregman DJ， Sullivan-Bolyai JZ，et al.Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program，United States，1976-1977[J]． Am J Epidemiol， 1979， 110(2)：105-123.DOI： 10.1093/oxfordjournals.aje.a112795.
|
| [45] |
Burwen DR， Ball R， Bryan WW，et al.Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001[J]． Am J Prev Med， 2010， 39(4)：296-304.DOI： 10.1016/j.amepre.2010.05.022.
|
| [46] |
Kaplan JE，Katona P，Hurwitz ES，et al.Guillain-Barré syndrome in the United States，1979-1980 and 1980-1981.Lack of an association with influenza vaccination[J]．JAMA，1982，248(6)：698-700.
|
| [47] |
Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines[J]． N Engl J Med， 1998， 339(25)：1797-1802.DOI： 10.1056/NEJM199812173392501.
|
| [48] |
Juurlink DN， Stukel TA， Kwong J，et al.Guillain-Barré syndrome after influenza vaccination in adults：a population-based study[J]． Arch Intern Med， 2006， 166(20)：2217-2221.DOI： 10.1001/archinte.166.20.2217.
|
| [49] |
Kao JC， Brickshawana A， Liewluck T．Neuromuscular complications of programmed cell death-1 (PD-1) inhibitors[J]． Curr Neurol Neurosci Rep， 2018， 18(10)：63.DOI： 10.1007/s11910-018-0878-7.
|
| [50] |
Hiew FL， Rajabally YA.Malignancy in Guillain-Barré syndrome：a twelve-year single-center study[J]． J Neurol Sci， 2017(375)：275-278.DOI： 10.1016/j.jns.2017.02.024.
|
| [51] |
Rudant J， Dupont A， Mikaeloff Y，et al.Surgery and risk of Guillain-Barré syndrome：a French nationwide epidemiologic study[J]． Neurology， 2018， 91(13)：e1220-e1227.DOI： 10.1212/WNL.0000000000006246.
|
| [52] |
Ho TW， Mishu B， Li CY，et al.Guillain-Barré syndrome in northern China.Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies[J]． Brain， 1995， 118 ( Pt 3)：597-605.DOI： 10.1093/brain/118.3.597.
|
| [53] |
Kuijf ML， van Doorn PA， Tio-Gillen AP，et al.Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA[J]． J Neurol Sci， 2005， 239(1)：37-44.DOI： 10.1016/j.jns.2005.07.009.
|
| [54] |
Uchibori A， Gyohda A， Chiba A．Ca(2+)-dependent anti-GQ1b antibody in GQ1b-seronegative Fisher syndrome and related disorders[J]． J Neuroimmunol， 2016(298)：172-177.DOI： 10.1016/j.jneuroim.2016.07.021.
|
| [55] |
Guillain G, Barré JA, Strohl A. Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction.Notes on clinical features and graphs of tendon reflexes.1916[J]．Ann Med Interne (Paris)，1999，150(1)：24-32.
|
| [56] |
Wong AH, Umapathi T, Nishimoto Y, et al. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes[J]． J Peripher Nerv Syst， 2015， 20(1)：47-51.DOI： 10.1111/jns.12104.
|
| [57] |
Vucic S， Cairns KD， Black KR，et al.Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy[J]． Clin Neurophysiol， 2004， 115(10)：2329-2335.DOI： 10.1016/j.clinph.2004.05.009.
|
| [58] |
Meulstee J, van der Meché FG. Electrodiagnostic criteria for polyneuropathy and demyelination：application in 135 patients with Guillain-Barré syndrome[J]． J Neurol Neurosurg Psychiatry， 1995， 59(5)：482-486.DOI： 10.1136/jnnp.59.5.482.
|
| [59] |
Berciano J， Sedano MJ， Pelayo-Negro AL, et al. Proximal nerve lesions in early Guillain-Barré syndrome：implications for pathogenesis and disease classification[J]． J Neurol， 2017， 264(2)：221-236.DOI： 10.1007/s00415-016-8204-2.
|
| [60] |
Kuwabara S， Sekiguchi Y， Misawa S．Electrophysiology in Fisher syndrome[J]． Clin Neurophysiol， 2017， 128(1)：215-219.DOI： 10.1016/j.clinph.2016.11.009.
|
| [61] |
Rajabally YA， Durand MC， Mitchell J, et al. Electrophysiological diagnosis of Guillain-Barré syndrome subtype：could a single study suffice？[J]． J Neurol Neurosurg Psychiatry， 2015， 86(1)：115-119.DOI： 10.1136/jnnp-2014-307815.
|
| [62] |
Uncini A, Kuwabara S. The electrodiagnosis of Guillain-Barré syndrome subtypes：where do we stand？[J]． Clin Neurophysiol， 2018， 129(12)：2586-2593.DOI： 10.1016/j.clinph.2018.09.025.
|
| [63] |
Van den Bergh P, Piéret F, Woodard JL, et al. Guillain-Barré syndrome subtype diagnosis：a prospective multicentric European study[J]． Muscle Nerve， 2018， 58(1)：23-28 .DOI： 10.1002/mus.26056.
|
| [64] |
Uncini A， Kuwabara S．Electrodiagnostic criteria for Guillain-Barrè syndrome：a critical revision and the need for an update[J]． Clin Neurophysiol， 2012， 123(8)：1487-1495.DOI： 10.1016/j.clinph.2012.01.025.
|
| [65] |
Gorson KC， Ropper AH， Muriello MA，et al.Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barré syndrome[J]． Neurology， 1996， 47(3)：813-817.DOI： 10.1212/wnl.47.3.813.
|
| [66] |
Yikilmaz A， Doganay S， Gumus H，et al.Magnetic resonance imaging of childhood Guillain-Barre syndrome[J]． Childs Nerv Syst， 2010， 26(8)：1103-1108.DOI： 10.1007/s00381-010-1197-8.
|
| [67] |
Elrick MJ， Gordon-Lipkin E， Crawford TO，et al.Clinical subpopulations in a sample of North American children diagnosed with Acute Flaccid Myelitis，2012-2016[J]． JAMA Pediatr， 2019， 173(2)：134-139.DOI： 10.1001/jamapediatrics.2018.
|
| [68] |
Hopkins SE， Elrick MJ， Messacar K．Acute flaccid myelitis-keys to diagnosis，questions about treatment，and future directions[J]． JAMA Pediatr， 2019， 173(2)：117-118.DOI： 10.1001/jamapediatrics.2018.4896.
|
| [69] |
Maloney JA， Mirsky DM， Messacar K，et al.MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak[J]． AJNR Am J Neuroradiol， 2015， 36(2)：245-250.DOI： 10.3174/ajnr.A4188.
|
| [70] |
Gallardo E， Sedano MJ， Orizaola P，et al.Spinal nerve involvement in early Guillain-Barré syndrome：a clinico-electrophysiological，ultrasonographic and pathological study[J]． Clin Neurophysiol， 2015， 126(4)：810-819.DOI： 10.1016/j.clinph.2014.06.051.
|
| [71] |
Razali S， Arumugam T， Yuki N，et al.Serial peripheral nerve ultrasound in Guillain-Barré syndrome[J]． Clin Neurophysiol， 2016， 127(2)：1652-1656.DOI： 10.1016/j.clinph.2015.06.030.
|
| [72] |
Dutch Association of Muscular Diseases & Dutch Society of Rehabilitation Specialists.Multidisciplinary guideline Guillain-Barré syndrome[M/OL].2011.
URL
|
| [73] |
Mehta S．Neuromuscular disease causing acute respiratory failure[J]．Respir Care，2006，51(9)：1016-1021.
|
| [74] |
Walgaard C, Lingsma HF, Ruts L, et al. Prediction of respiratory insufficiency in Guillain-Barré syndrome[J]． Ann Neurol， 2010， 67(6)：781-787.DOI： 10.1002/ana.21976.
|
| [75] |
Walgaard C， Lingsma HF， van Doorn PA，et al.Tracheostomy or not：prediction of prolonged mechanical ventilation in Guillain-Barré syndrome[J]． Neurocrit Care， 2017， 26(1)：6-13.DOI： 10.1007/s12028-016-0311-5.
|
| [76] |
Hughes RA， Swan AV， van Doorn PA.Intravenous immunoglobulin for Guillain-Barré syndrome[J]． Cochrane Database Syst Rev， 2014， 2014(9)：CD002063.DOI： 10.1002/14651858.CD002063.pub6.
|
| [77] |
Chevret S， Hughes RA， Annane D．Plasma exchange for Guillain-Barré syndrome[J]． Cochrane Database Syst Rev， 2017， 2(2)：CD001798.DOI： 10.1002/14651858.CD001798.pub3.
|
| [78] |
Korinthenberg R， Schessl J， Kirschner J，et al.Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome：a randomized trial[J]． Pediatrics， 2005， 116(1)：8-14.DOI： 10.1542/peds.2004-1324.
|
| [79] |
Appropriate number of plasma exchanges in Guillain-Barré syndrome.The French cooperative group on plasma exchange in Guillain-Barré syndrome[J]． Ann Neurol， 1997， 41(3)：298-306.DOI： 10.1002/ana.410410304. |
| [80] |
Verboon C， van Doorn PA， Jacobs BC.Treatment dilemmas in Guillain-Barré syndrome[J]． J Neurol Neurosurg Psychiatry， 2017， 88(4)：346-352.DOI： 10.1136/jnnp-2016-314862.
|
| [81] |
Raphaël JC， Chevret S， Hughes RA，et al.Plasma exchange for Guillain-Barré syndrome[J]． Cochrane Database Syst Rev， 2012(7)：CD001798.DOI： 10.1002/14651858.
|
| [82] |
Hughes RA， Swan AV， Raphaël JC，et al.Immunotherapy for Guillain-Barré syndrome：a systematic review[J]． Brain， 2007， 130(Pt 9)：2245-2257.DOI： 10.1093/brain/awm004.
|
| [83] |
van Koningsveld R， Schmitz PI， Meché FG，et al.Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome：randomised trial[J]． Lancet， 2004， 363(9404)：192-196.DOI： 10.1016/s0140-6736(03)15324-x.
|
| [84] |
Islam MB， Islam Z， Rahman S，et al.Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings：a safety and feasibility study[J]． Pilot Feasibility Stud， 2017(3)：40.DOI： 10.1186/s40814-017-0185-0.
|
| [85] |
Overell JR, Hsieh ST, Odaka M, et al. Treatment for Fisher syndrome，Bickerstaff's brainstem encephalitis and related disorders[J]． Cochrane Database Syst Rev， 2007， 2007(1)：CD004761.DOI： 10.1002/14651858.CD004761.pub2.
|
| [86] |
Verboon C， Doets AY， Galassi G，et al.Current treatment practice of Guillain-Barré syndrome[J]． Neurology， 2019， 93(1)：e59-e76.DOI： 10.1212/WNL.0000000000007719.
|
| [87] |
Tomimatsu T， Sugihara M， Nagai T，et al.Guillain-Barré syndrome after trivalent influenza vaccination during pregnancy[J]． Eur J Obstet Gynecol Reprod Biol， 2016(201)：225-226.DOI： 10.1016/j.ejogrb.2016.03.031.
|
| [88] |
Pacheco LD， Saad AF， Hankins GD，et al.Guillain-Barré syndrome in pregnancy[J]． Obstet Gynecol， 2016， 128(5)：1105-1110.DOI： 10.1097/AOG.0000000000001716.
|
| [89] |
Branch DW， Porter TF， Paidas MJ，et al.Obstetric uses of intravenous immunoglobulin：successes，failures，and promises[J]． J Allergy Clin Immunol， 2001， 108(4 Suppl)：S133-S138.DOI： 10.1067/mai.2001.117821.
|
| [90] |
El-Bayoumi MA， El-Refaey AM， Abdelkader AM，et al.Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome：a randomized study[J]． Crit Care， 2011， 15(4)：R164.DOI： 10.1186/cc10305.
|
| [91] |
|
| [92] |
Kannan Kanikannan MA， Durga P， Venigalla NK，et al.Simple bedside predictors of mechanical ventilation in patients with Guillain-Barre syndrome[J]． J Crit Care， 2014， 29(2)：219-223.DOI： 10.1016/j.jcrc.2013.10.026.
|
| [93] |
Lawn ND， Fletcher DD， Henderson RD，et al.Anticipating mechanical ventilation in Guillain-Barré syndrome[J]． Arch Neurol， 2001， 58(6)：893-898.DOI： 10.1001/archneur.58.6.893.
|
| [94] |
Hughes RA， Newsom-Davis JM， Perkin GD，et al.Controlled trial prednisolone in acute polyneuropathy[J]． Lancet， 1978， 2(8093)：750-753.DOI： 10.1016/s0140-6736(78)92644-2.
|
| [95] |
Dhar R， Stitt L， Hahn AF.The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit[J]． J Neurol Sci， 2008， 264(1-2)：121-128.DOI： 10.1016/j.jns.2007.08.005.
|
| [96] |
Oczko-Walker M， Manousakis G， Wang S，et al.Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome：critical reassessment of effectiveness and cost-efficiency[J]． J Clin Neuromuscul Dis， 2010， 12(2)：55-61.DOI： 10.1097/CND.0b013e3181f3dbbf.
|
| [97] |
Farcas P， Avnun L， Frisher S，et al.Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome[J]． Lancet， 1997， 350(9093)：1747.DOI： 10.1016/s0140-6736(97)24050-x.
|
| [98] |
Walgaard C， Jacobs BC， Lingsma HF，et al.Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial)：protocol for a double-blind randomized，placebo-controlled clinical trial[J]． J Peripher Nerv Syst， 2018， 23(4)：210-215.DOI： 10.1111/jns.12286.
|
| [99] |
van den Berg B， Storm EF， Garssen M，et al.Clinical outcome of Guillain-Barré syndrome after prolonged mechanical ventilation[J]． J Neurol Neurosurg Psychiatry， 2018， 89(9)：949-954.DOI： 10.1136/jnnp-2018-317968.
|
| [100] |
Walgaard C， Lingsma HF， Ruts L，et al.Early recognition of poor prognosis in Guillain-Barre syndrome[J]． Neurology， 2011， 76(11)：968-975.DOI： 10.1212/WNL.0b013e3182104407.
|
| [101] |
Soysal A， Aysal F， Caliskan B，et al.Clinico-electrophysiological findings and prognosis of Guillain-Barré syndrome-10 years′ experience[J]． Acta Neurol Scand， 2011， 123(3)：181-186.DOI： 10.1111/j.1600-0404.2010.01366.x.
|
| [102] |
Bersano A， Carpo M， Allaria S，et al.Long term disability and social status change after Guillain-Barré syndrome[J]． J Neurol， 2006， 253(2)：214-218.DOI： 10.1007/s00415-005-0958-x.
|
| [103] |
Forsberg A， Press R， Holmqvist LW.Residual disability 10 years after falling ill in Guillain-Barré syndrome：a prospective follow-up study[J]． J Neurol Sci， 2012， 317(1-2)：74-79.DOI： 10.1016/j.jns.2012.02.026.
|
| [104] |
Simatos Arsenault N， Vincent PO， Yu BH，et al.Influence of exercise on patients with Guillain-Barré syndrome：a systematic review[J]． Physiother Can， 2016， 68(4)：367-376.DOI： 10.3138/ptc.2015-58.
|
| [105] |
Garssen MP， Van Koningsveld R， Van Doorn PA.Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome[J]． J Neurol， 2006， 253(9)：1143-1146.DOI： 10.1007/s00415-006-0163-6.
|
| [106] |
Merkies IS， Schmitz PI， Samijn JP，et al.Fatigue in immune-mediated polyneuropathies.European Inflammatory Neuropathy Cause and Treatment (INCAT) group[J]． Neurology， 1999， 53(8)：1648-1654.DOI： 10.1212/wnl.53.8.1648.
|
| [107] |
Garssen MP， Bussmann JB， Schmitz PI，et al.Physical training and fatigue，fitness，and quality of life in Guillain-Barré syndrome and CIDP[J]． Neurology， 2004， 63(12)：2393-2395.DOI： 10.1212/01.wnl.0000148589.87107.9c.
|
| [108] |
Hughes RA, Wijdicks EF, Benson E, et al. Supportive care for patients with Guillain-Barré syndrome[J]． Arch Neurol， 2005， 62(8)：1194-1198.DOI： 10.1001/archneur.62.8.1194.
|
| [109] |
Bernsen RA， de Jager AE， Kuijer W，et al.Psychosocial dysfunction in the first year after Guillain-Barré syndrome[J]． Muscle Nerve， 2010， 41(4)：533-539.DOI： 10.1002/mus.21536.
|
| [110] |
Wang Y， Shi Q， Lv H，et al.IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome[J]． Exp Neurol， 2017(291)：134-140.DOI： 10.1016/j.expneurol.2017.02.010.
|
| [111] |
Misawa S， Kuwabara S， Sato Y，et al.Safety and efficacy of eculizumab in Guillain-Barré syndrome：a multicentre，double-blind，randomised phase 2 trial[J]． Lancet Neurol， 2018， 17(6)：519-529.DOI： 10.1016/S1474-4422(18)30114-5.
|
| [112] |
Wakerley BR， Yuki N．Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes[J]． Pract Neurol， 2015， 15(2)：90-99.DOI： 10.1136/practneurol-2014-000937.
|
| [113] |
Wakerley BR， Kokubun N， Funakoshi K，et al.Clinical classification of 103 Japanese patients with Guillain-Barré syndrome[J]． J Neurol Sci， 2016(369)：43-47.DOI： 10.1016/j.jns.2016.08.002.
|
| [114] |
Hiew FL, Ramlan R, Viswanathan S, et al. Guillain-Barré Syndrome，variants & forms fruste：Reclassification with new criteria[J]． Clin Neurol Neurosurg， 2017(158)：114-118.DOI： 10.1016/j.clineuro.2017.05.006.
|
| [115] |
Blum S， Reddel S， Spies J，et al.Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia[J]． J Peripher Nerv Syst， 2013， 18(4)：316-320.DOI： 10.1111/jns5.12045.
|
| [116] |
Peric S， Milosevic V， Berisavac I，et al.Clinical and epidemiological features of Guillain-Barré syndrome in the Western Balkans[J]． J Peripher Nerv Syst， 2014， 19(4)：317-321.DOI： 10.1111/jns.12096.
|
| [117] |
Zhang G， Li Q， Zhang R，et al.Subtypes and prognosis of Guillain-Barré syndrome in Southwest China[J]． PLoS One， 2015， 10(7)：e0133520.DOI： 10.1371/journal.pone.0133520.
|
| [118] |
Mitsui Y， Kusunoki S， Arimura K，et al.A multicentre prospective study of Guillain-Barré syndrome in Japan：a focus on the incidence of subtypes[J]． J Neurol Neurosurg Psychiatry， 2015， 86(1)：110-114.DOI： 10.1136/jnnp-2013-306509.
|
| [119] |
Ishaque T， Islam MB， Ara G，et al.High mortality from Guillain-Barré syndrome in Bangladesh[J]． J Peripher Nerv Syst， 2017， 22(2)：121-126.DOI： 10.1111/jns.12215.
|